PainChek Limited

Equities

PCK

AU000000PCK6

Software

Market Closed - Australian S.E. 02:10:45 2024-04-26 am EDT 5-day change 1st Jan Change
0.031 AUD +3.33% Intraday chart for PainChek Limited +3.33% -16.22%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
PainChek Secures AU$1,210,000 R&D Tax Incentive MT
PainChek Establishes Reseller Agreement with UK-Based Nourish Care; Shares Rise 3% MT
PainChek Raises AU$5 Million via Share Placement MT
Painchek's Share Purchase Plan Closes Oversubscribed MT
PainChek Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
PainChek Limited Announces Change of Company Secretary CI
Painchek Secures Notice of Acceptance for Pain Assessment Patent Application in Europe MT
PainChek to Raise Nearly AU$4 Million from Placement MT
PainChek Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
PainChek Receives AU$1 Million R&D Tax Rebate MT
Painchek Signs Distribution Agreement with Pain Diagnostic Specialist Ethos Laboratories MT
PainChek Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
PainChek Limited Announces Company Secretary Changes CI
Painchek Expands Activities to Japan with JETRO Business Connect Program for 2022 MT
PainChek Limited Expands Activities to Japan with JETRO Business Connect CI
PainChek Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
PainChek Limited Auditor Raises 'Going Concern' Doubt CI
PainChek Secures Grant Funding for Trial of Pain Assessment App in Welsh Care Facilities MT
PainChek Secures Government Funding for Development of Specialized Pain Management App; Shares Rally 12% MT
Painchek Limited to Receive Govt Funding for Children's Disability App CI
Painchek Grows Global Recognized Revenue by 66% in Fiscal Q3 MT
PainChek Ltd Appoints Cynthia Payne as Non-Executive Director, Effective 30 March 2022 CI
Painchek Rolls Out Pain Management Application at Summerset’s New Zealand Facilities; Shares Rise 3% MT
Summerset Holdings Rolls Out Painchek's Pain Assessment Solution Across All Care Centers in New Zealand CI
PainChek Limited Reports Earnings Results for the Half Year Ended December 31, 2021 CI
Chart PainChek Limited
More charts
PainChek Ltd is an Australia-based company, which develops pain assessment technologies. The Company’s principal activities are development and commercialization of mobile medical device applications that provide pain assessment for individuals that are unable to communicate with their carers. The Company’s PainChek Universal is a complete point-of-care solution that combines the existing PainChek Application with the numerical rating scale (NRS). PainChek Application uses artificial intelligence and facial recognition to detect pain in those who cannot self-report. This gives a voice to those who cannot verbalize pain, whilst also driving objectivity and consistency in all assessments. For those who can self-report, PainChek Universal also includes access to the NRS, a standard used to document pain levels amongst these individuals. PainChek Universal also supports pain assessment using both tools at the point of care, for those people whose ability to communicate fluctuates.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PCK Stock
  4. News PainChek Limited
  5. Painchek's Share Purchase Plan Closes Oversubscribed